• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脆性骨折治疗项目:它们有效吗?外科医生的作用是什么?

Fragility fracture programs: are they effective and what is the surgeon's role?

作者信息

Bender Jay S, Meinberg Eric G

机构信息

SFGH/UCSF Orthopaedic Trauma Institute, Department of Orthopaedic Surgery, University of California, San Francisco, 2550 23rd Street, Building 9, 2nd Floor, San Francisco, CA, 94110, USA.

出版信息

Curr Osteoporos Rep. 2015 Feb;13(1):30-4. doi: 10.1007/s11914-014-0251-y.

DOI:10.1007/s11914-014-0251-y
PMID:25501751
Abstract

Fragility fractures are occurring at an ever-increasing rate, creating an enormous economic and societal impact. Outpatient-based fragility fracture programs have been developed to identify at-risk patients, initiate effective treatment of metabolic bone disease, and improve coordination between members of the patient's care team with the goal of reducing future fractures. Inpatient programs focus on effective, efficient management of patients presenting with acute fractures. Both have proven successful in reducing the impact of fragility fractures, but many challenges exist. The orthopedic surgeon, as part of an integrated team of providers, is integral in identifying at-risk patients, ensuring appropriate care of acute fractures, and initiating treatment protocols to reduce the risk of further injuries.

摘要

脆性骨折的发生率正以越来越快的速度上升,造成了巨大的经济和社会影响。已开展了基于门诊的脆性骨折项目,以识别高危患者,启动代谢性骨病的有效治疗,并改善患者护理团队成员之间的协调,目标是减少未来骨折的发生。住院项目则侧重于对急性骨折患者进行有效、高效的管理。两者都已证明在减少脆性骨折的影响方面取得了成功,但仍存在许多挑战。作为综合医疗团队的一员,骨科医生在识别高危患者、确保急性骨折得到适当护理以及启动治疗方案以降低进一步受伤风险方面起着不可或缺的作用。

相似文献

1
Fragility fracture programs: are they effective and what is the surgeon's role?脆性骨折治疗项目:它们有效吗?外科医生的作用是什么?
Curr Osteoporos Rep. 2015 Feb;13(1):30-4. doi: 10.1007/s11914-014-0251-y.
2
Multinational survey of osteoporotic fracture management.骨质疏松性骨折管理的多国调查。
Osteoporos Int. 2005 Mar;16 Suppl 2:S44-53. doi: 10.1007/s00198-004-1700-8. Epub 2004 Sep 16.
3
Osteoporotic Fracture Program management: who should be in charge? A comparative survey of knowledge in orthopaedic surgeons and internists.骨质疏松性骨折项目管理:应由谁负责?骨科医生和内科医生知识的比较调查。
Orthop Traumatol Surg Res. 2013 Oct;99(6):723-30. doi: 10.1016/j.otsr.2013.03.022. Epub 2013 Jul 10.
4
Surgeons save bones: an algorithm for orthopedic surgeons managing secondary fracture prevention.外科医生拯救骨骼:骨科医生管理二次骨折预防的算法。
Arch Orthop Trauma Surg. 2013 Aug;133(8):1101-8. doi: 10.1007/s00402-013-1774-x. Epub 2013 May 17.
5
Effective initiation of osteoporosis diagnosis and treatment for patients with a fragility fracture in an orthopaedic environment.在骨科环境中对脆性骨折患者进行骨质疏松症诊断和治疗的有效启动。
J Bone Joint Surg Am. 2006 Jan;88(1):25-34. doi: 10.2106/JBJS.E.00198.
6
Medical management of osteoporosis and the surgeons' role.骨质疏松症的医学管理及外科医生的作用。
Injury. 2016 Jan;47 Suppl 1:S62-4. doi: 10.1016/S0020-1383(16)30014-6.
7
Bridging the osteoporosis treatment gap: performance and cost-effectiveness of a fracture liaison service.弥合骨质疏松症治疗差距:骨折联络服务的成效与成本效益
J Clin Densitom. 2015 Apr-Jun;18(2):150-6. doi: 10.1016/j.jocd.2015.01.003. Epub 2015 Mar 18.
8
Epidemiology and economic burden of osteoporosis in Switzerland.瑞士的骨质疏松症流行病学和经济负担。
Arch Osteoporos. 2014;9:187. doi: 10.1007/s11657-014-0187-y. Epub 2014 Jun 27.
9
Cost-effectiveness of a fracture liaison service--a real-world evaluation after 6 years of service provision.骨折联络服务的成本效益——服务提供6年后的实际评估
Osteoporos Int. 2016 Jan;27(1):231-40. doi: 10.1007/s00198-015-3280-1. Epub 2015 Aug 15.
10
Evaluation and medical management of fragility fractures of the upper extremity.上肢脆性骨折的评估与药物治疗
Orthop Clin North Am. 2014 Apr;45(2):233-43. doi: 10.1016/j.ocl.2013.12.005. Epub 2014 Jan 23.

本文引用的文献

1
Do bisphosphonates affect bone healing? A meta-analysis of randomized controlled trials.双膦酸盐会影响骨愈合吗?一项随机对照试验的荟萃分析。
J Orthop Surg Res. 2014 Jun 5;9:45. doi: 10.1186/1749-799X-9-45.
2
Osteoporosis and the orthopaedic surgeon: basic concepts for successful co-management of patients' bone health.骨质疏松症与骨科医生:成功共同管理患者骨骼健康的基本概念
Int Orthop. 2014 Aug;38(8):1731-8. doi: 10.1007/s00264-014-2317-y. Epub 2014 Mar 21.
3
The potential economic benefits of improved postfracture care: a cost-effectiveness analysis of a fracture liaison service in the US health-care system.
骨折后护理改善的潜在经济效益:美国医疗保健系统中骨折联络服务的成本效益分析。
J Bone Miner Res. 2014 Jul;29(7):1667-74. doi: 10.1002/jbmr.2180.
4
Effect of early administration of alendronate after surgery for distal radial fragility fracture on radiological fracture healing time.桡骨远端脆性骨折术后早期应用阿仑膦酸钠对影像学骨折愈合时间的影响。
Bone Joint J. 2013 Nov;95-B(11):1544-50. doi: 10.1302/0301-620X.95B11.31652.
5
A Year of Fractures: a snapshot analysis of the logistics, problems and outcomes of a hospital-based fracture liaison service.骨折年:医院骨折联络服务的后勤、问题和结果的快照分析。
Osteoporos Int. 2013 Oct;24(10):2619-25. doi: 10.1007/s00198-013-2357-y. Epub 2013 Apr 19.
6
The impact of comorbidity on perioperative outcomes of hip fractures in a geriatric fracture model.共病对老年骨折模型中髋部骨折围手术期结局的影响。
Geriatr Orthop Surg Rehabil. 2012 Sep;3(3):129-34. doi: 10.1177/2151458512463392.
7
Diagnosis and treatment of osteoporosis in high-risk patients prior to hip fracture.髋部骨折高危患者骨质疏松症的诊断与治疗
Geriatr Orthop Surg Rehabil. 2012 Jun;3(2):79-83. doi: 10.1177/2151458512454878.
8
Comparison of an organized geriatric fracture program to United States government data.一个有组织的老年骨折项目与美国政府数据的比较。
Geriatr Orthop Surg Rehabil. 2010 Sep;1(1):15-21. doi: 10.1177/2151458510382231.
9
The 1-year mortality of patients treated in a hip fracture program for elders.老年髋部骨折治疗项目中患者的1年死亡率。
Geriatr Orthop Surg Rehabil. 2010 Sep;1(1):6-14. doi: 10.1177/2151458510378105.
10
Evaluation of a program of integrated care to reduce recurrent osteoporotic fractures.评估一项综合护理计划以减少复发性骨质疏松性骨折。
Pharmacoepidemiol Drug Saf. 2013 Mar;22(3):263-70. doi: 10.1002/pds.3399. Epub 2013 Jan 7.